Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,546.80
(
0.11%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
96.66
(
0.17%
)
Bitcoin
71,172.98
(
0.93%
)
News Focus
News Focus

Replies to post #3997 on GTC Biotherapeutics (fka GTCB)

Replies to #3997 on GTC Biotherapeutics (fka GTCB)
icon url

DewDiligence

06/30/07 6:57 PM

#3998 RE: croumagnon #3997

>I realize that cost and supply make the recombinant [antithrombin] very attractive but is that the only advantage?<

The main advantage is safety.